YS Biopharma Co Ltd banner

YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 0.627 USD -24.46% Market Closed
Market Cap: $2.6m

YS Biopharma Co Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

YS Biopharma Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
YS Biopharma Co Ltd
NASDAQ:LSB
Inventory
¥227.6m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Inventory
¥3.6B
CAGR 3-Years
32%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Inventory
¥1.1B
CAGR 3-Years
-9%
CAGR 5-Years
19%
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
Inventory
¥659.4m
CAGR 3-Years
33%
CAGR 5-Years
84%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Inventory
¥706.5m
CAGR 3-Years
53%
CAGR 5-Years
115%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Inventory
¥63m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

YS Biopharma Co Ltd
Glance View

Market Cap
2.6m USD
Industry
Biotechnology

YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company is headquartered in Beijing, Beijing. The firm's vaccine product YSJATM rabies vaccine has been commercialized. The firm also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

LSB Intrinsic Value
Not Available

See Also

What is YS Biopharma Co Ltd's Inventory?
Inventory
227.6m CNY

Based on the financial report for Mar 31, 2025, YS Biopharma Co Ltd's Inventory amounts to 227.6m CNY.

What is YS Biopharma Co Ltd's Inventory growth rate?
Inventory CAGR 3Y
11%

Over the last year, the Inventory growth was 12%. The average annual Inventory growth rates for YS Biopharma Co Ltd have been 11% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett